Astronaut Meds Go Commercial


NASA Signs Agreement to Develop Nasal Spray for Motion Sickness, NASA (with full text of Space Act Agreement)

"Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form."

Epiomed and NASA Sign Space Act Agreement for INSCOP, an Intra-nasal Scopolamine Product

"Epiomed will take responsibility for further development and commercialization of INSCOP, assisted by NASA-HH&P (Human Health & Performance Directorate) technology, and assume sponsorship of the IND (Investigational New Drug) from NASA under the SAA."

  • submit to reddit


Loading




Join our mailing list




Commercialization: Monthly Archives

Monthly Archives

About this Entry

This page contains a single entry by Keith Cowing published on October 12, 2012 6:44 PM.

Lugo's Big Mistake: Changes Ahead at GRC Halted was the previous entry in this blog.

Red Bull Stratos Jump Successful is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.